Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908)
10/2004
10/06/2004EP1463517A2 Analyse permettant de detecter des facteurs qui modulent l'expression d'ingap
10/06/2004EP1463497A2 Treating muscle wasting with selective androgen receptor modulators
10/06/2004EP1383481B1 Process for manufacture of biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
10/06/2004EP1318837B1 Method of treating estrogen receptor positive carcinoma
10/06/2004CN1535261A New phenylalkyloxy-phenyl derivatives
10/06/2004CN1535168A Controlled release composition and method of producing the same
10/06/2004CN1535155A Pharmaceutical combination comprising either (S)-2-ethyxy-3 [4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{4-[2-(4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}
10/06/2004CN1535144A Pharmaceutical combination comprising either (S)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic aicd or 3-{4-[2-(4-tert-butoxy carbonyl aminophenyl) ethyoxy] phenyl}
10/06/2004CN1535141A Sustained-release composition and process for producing the same
10/05/2004US6800778 Process for producing optically active naphthalene derivative and optical resolver therefor
10/05/2004US6800740 Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications
10/05/2004US6800635 Crystallization from solvent at low temperature or slurrying procedure
10/05/2004US6800620 Contacting leukocytes, osteoclasts with an enzyme inhibitors, a 9h-purin-3h-quinazolin-4-one derivatives, treating bone-resorption disorder, antiproliferative agents treating leukemia cells
10/05/2004US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives
10/05/2004US6800605 With a hypolipidemic agent, an antidiabetic agent, an antidepressant, a bone resorption inhibitor, an appetite suppressant and/or an anti-obesity agent
10/05/2004CA2264243C Glp-1 derivatives
09/2004
09/30/2004WO2004083243A1 Amylin aggregation inhibitors and use thereof.
09/30/2004WO2004083184A1 Receptor antagonist
09/30/2004WO2003087333A8 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
09/30/2004WO2003068197A8 Method for systemic drug delivery through the nail
09/30/2004US20040192685 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
09/30/2004US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents
09/30/2004US20040192608 Treatment of obesity
09/30/2004US20040191827 Modulators of the hypocretin system and methods of screening therefor
09/30/2004CA2516726A1 Amylin aggregation inhibitors and use thereof
09/29/2004EP1462442A1 Crystals of bicalutamide and process for their production
09/29/2004EP1461443A2 Carbohydrate-associated proteins
09/29/2004EP1461421A2 A method for the establishment of a pluripotent human blastocyst-derived stem cell line
09/29/2004EP1461334A2 Pyrazole derived kinase inhibitors
09/29/2004EP1461327A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/29/2004EP1461325A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
09/29/2004EP1461122A2 Treatment of genitourinary tract disorders
09/29/2004EP1461068A1 Methods of compositions for normalizing lipid levels in mammalian tissues
09/29/2004EP1461043A1 Oral pharmaceutical products containing 17 beta-estradiol-3 lower alkanoate, method of administering the same and process of preparation
09/29/2004EP1461038A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
09/29/2004EP1460995A1 Transdermal transport of compounds
09/29/2004EP1460969A2 Prevention and treatment of androgen-deprivation induced osteoporosis
09/29/2004EP1389202B1 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
09/29/2004EP1100483B1 Glucocorticoid-selective anti-inflammatory agents
09/29/2004CN1533435A Methods and reagents for diagnosis and treatment of insulin resistance and related conditions
09/29/2004CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use
09/29/2004CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases
09/29/2004CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use
09/29/2004CN1168499C Medicament for optimising mucosal viscosity and stimulating intestinal function
09/28/2004US6797693 Methods using PTPase inhibitors and insulin
09/28/2004US6797489 PP14 fusion proteins and methods for making and using the same
09/28/2004US6797258 Compositions and methods for the pulmonary delivery of aerosolized macromolecules
09/23/2004WO2004080479A1 Gonadal function improving agents
09/23/2004WO2004080467A2 Method of treating and preventing hyperparathyroidism with vitamin d2 or d4 compounds
09/23/2004US20040186299 such as 3-(3,5-dimethoxyphenyl)-2-{4-[4-(2,4-dioxothiazolidin-5-ylmethyl)-phenoxy]-phenyl}-acrylic acid; for lowering blood glucose level, serum insulin, triglyceride and free fatty acid levels in animal models of Type II diabetes; for increasing leptin levels with no liver toxicity
09/23/2004US20040186179 Pharmaceutical composition
09/23/2004US20040186132 Steroid receptor modulator compounds and methods
09/23/2004US20040186086 Estetrol and estetrol-like substances have relatively low estrogenic potency, metabolic stability, long half-life; triene steroids
09/23/2004US20040186045 Compositions and methods for enhancing drug delivery across and into epithelial tissues
09/23/2004US20040185546 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering
09/23/2004US20040185507 Isolated monoclonal antibody comprising a light and heavy chain variable of given sequence; diagnosing, treating and preventing prostate/colon cancer and renal carcinoma
09/23/2004US20040185113 Sparingly water-soluble calcium-containing inorganic microparticles and a drug or biodrug encapsulated therein; made by adding a calcium compound to a solution of a carbonate, phosphate, oxalate or urate and the drug to form the calcium salt of the carbonate, phosphate, oxalate or urate
09/23/2004US20040185048 Modulation of IL-2- and IL-15-mediated T cell responses
09/23/2004US20040184992 Mousse composition
09/23/2004CA2518541A1 Gonadal function improving agents
09/23/2004CA2517160A1 Method of treating and preventing hyperparathyroidism with vitamin d compounds
09/22/2004EP1459759A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood
09/22/2004EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same
09/22/2004EP1458743A1 Tetrahydrobenzfluorene derivatives
09/22/2004EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
09/22/2004EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
09/22/2004EP1458712A2 Novel compounds
09/22/2004EP1458700A2 Substituted 2-phenyl benzofurans as estrogenic agents
09/22/2004EP1458399A1 Pregnane steroids for use in the treatment of cns disorders
09/22/2004EP1458392A2 Acridone inhibitors of impdh enzyme
09/22/2004EP1458386A1 Aroyl pyrrole heteroeryl and methanols useful for treating a central nervous system disorder
09/22/2004EP1458382A1 Amide derivatives as gk activators
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458363A1 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
09/22/2004EP1458352A1 Solid dose micro implant
09/22/2004EP1458347A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof
09/22/2004EP1196428B1 11-beta-aryl-17,17-spirothiolane-substituted steroids
09/22/2004EP1163264B1 Novel lhrh antagonists with improved solubility characteristics
09/22/2004CN1531550A Heterocarpine, human GHRH-binding protein
09/22/2004CN1531537A Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists
09/22/2004CN1531433A Synergistic pharmaceutical combination for prevention or treatment of diabetes
09/22/2004CN1531423A Preparation of low dosage medicinal composition with uniform distribution and effect
09/22/2004CN1530107A Insulin resistance treatment by growth hormone secretory hormone
09/22/2004CN1530106A Medicine composition for treating diabet mellitus
09/22/2004CN1530105A Medicine composition for treating diabets and mellitus
09/22/2004CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands
09/22/2004CN1167687C Arylpyridazinones as prostaglandin endoperoxide H synthase biosynthesis inhibitors
09/21/2004US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease
09/21/2004US6794415 Biphenyl compounds and their use as oestrogenic agents
09/21/2004US6794406 For therapy and prophylaxis of arteriosclerosis and hypercholesterolaemia
09/21/2004US6794403 Substituted benzoxazoles as estrogenic agents
09/21/2004US6794382 Benzimidazole derivatives, preparation and therapeutic use thereof
09/21/2004US6794380 Amide derivatives
09/21/2004US6794169 Enzymatic polypeptide for use in the biosynthesis of glycans
09/21/2004US6793924 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated t cells and thereby inhibits t cell activation of b cells
09/21/2004CA2280587C Growth hormone secretagogues
09/16/2004WO2004078947A2 Use of thyroid-stimulating hormone to induce lipolysis
09/16/2004WO2004078723A1 Novel compound having 4-pyridylalkylthio group as substituent
09/16/2004WO2004062557A3 Pharmaceutical combination of telmisartan and atorvastatin for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases